Abstract
The presence of circulating anti-HLA antibodies in patients (pts) awaiting heart transplant (HTx) limits the available donor pool. The predicted difficulty in finding a donor heart is based on the calculated panel reactive antibody (cPRA). The cPRA is the percentage of donor hearts in a given population to which a HTx candidate will have anti-HLA antibodies; thus, the higher the cPRA, the harder it is to find a suitable donor. The aim of the current study was to determine if desensitization protocols could successfully reduce cPRA for pts awaiting transplant in a large cohort of sensitized pts.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Paper Title
Journal
Date
